Skip to main content
. 2018 Sep 5;12:94–100. doi: 10.1016/j.pmedr.2018.09.002

Table 1.

Characteristics of the study population.

Characteristics
Number of participants (n) 37
 Participants with 3 days data, n (%) 1 (2.7%)
 Participants with >3–<7 days data, n (%) 9 (24.3%)
 Participants with ≥7 days data, n (%) 27 (72.9%)
Age (years) 62.8 ± 10.5
Sex, male/female (n) 14/23
BMI (kg/m2) 29.6 ± 6.8
HbA1c (mmol/mol), (n = 15 missing) 47.7 ± 10.6
HbA1c (%), (n = 15 missing) 6.6 ± 0.9
Diabetes management (n)
 No medication/diet modification alone 12
 Metformin 18
 Metformin + sulfonylurea 5
 Metformin + gliptin 1
 Metformin + sulfonylurea + gliptin 1
Alcohol consumption (n)
 Non-consumer 18
 Low consumer (≤14 units per week) 18
 High consumer (>14 units per week) 1
Smoking status (n)
 Non-smoker 34
 Smoker 3
Carbohydrate intake (g/day) 125.3 ± 21.1
Energy expenditure (MET × h/day) 33.6 ± 1.3
Sedentary time (h/day) 9.8 ± 1.8
Breaks in sedentary time (n/day) 52 ± 13
Standing time (h/day) 4.0 ± 1.5
Walking time (h/day) 1.6 ± 0.6
MVPA time (min/day) 32.1 ± 22.7
CGM and activPAL3 recording time (days) 10 ± 3.4
CGM recording h/day 22.4 ± 1.8
Time in hypoglycaemia (% of recording h/day) 3.7 ± 6.9
Time in euglycaemia (% of recording h/day) 64.7 ± 25.5
Time in hyperglycaemia (% of recording h/day) 32.1 ± 27.4
Time above target (% of recording h/day) 19.2 ± 20.8
Hypoglycaemic events (n/day) 0.7 ± 1.0
Euglycaemic events (n/day) 3.9 ± 1.1
Hyperglycaemic events (n/day) 2.9 ± 1.3
Events above target (n/day) 2.3 ± 1.4

Data are means ± SD or number (n). BMI, body mass index; MET, metabolic equivalent task.